Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.88% | -24.76% | -16.40% | -27.66% | -41.60% |
| Total Depreciation and Amortization | 26.66% | 23.71% | 21.22% | 18.96% | 17.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 352.57% | 267.15% | -159.08% | -190.38% | -134.98% |
| Change in Net Operating Assets | 206.81% | -37.54% | -102.38% | 267.05% | 189.41% |
| Cash from Operations | -17.57% | -26.37% | -35.77% | -23.18% | -27.08% |
| Capital Expenditure | -91.09% | -15.22% | -32.76% | 9.96% | 64.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -704.98% | -389.74% | 239.11% | 220.09% | 11,590.16% |
| Cash from Investing | -1,881.05% | -24,694.78% | 160.13% | 178.03% | 124.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 153.88% | 153.88% | 133.26% | 49.84% | -31.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -184.74% | -171.54% | -86.86% | -93.92% | -8.85% |
| Cash from Financing | 130.92% | 131.73% | 141.20% | 49.00% | -27.79% |
| Foreign Exchange rate Adjustments | -50.00% | 282.26% | 304.86% | 2,492.51% | -18.67% |
| Miscellaneous Cash Flow Adjustments | 19,200.00% | -- | -- | -- | -- |
| Net Change in Cash | 228.16% | 369.10% | 1,132.60% | 400.85% | -197.83% |